Company Profile

Nanosphere Inc (AKA: Nanosphere LLC)
Profile last edited on: 4/26/2019      CAGE: 1ZDW3      UEI: DNQ4H6RCTMJ5

Business Identifier: Molecular diagnostics: simplified molecular testing based on nanoparticles of gold
Year Founded
1999
First Award
2000
Latest Award
2007
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4088 Commercial Avenue
Northbrook, IL 60062
   (847) 400-9000
   info@nanosphere.us
   www.nanosphere.us
Location: Single
Congr. District: 10
County: Cook

Public Profile

In May 2016, Nanosphere was acquired by Luminex Corporation itself and SBIR -involved firm - in a cash deal reported as $77M also to include retiring $25M of Nanosphere's debt. Nanosphere, Inc. had been organized around a molecular diagnostics platform -- Verigene System -- that enabled genomic and protein testing on a single platform. The firm's proprietary nanoparticle technology provided the ability to run multiple tests simultaneously on the same sample, as well as simplifies molecular diagnostic testing. The company developed diagnostic tests for markers, which reveal the existence of various medical conditions, including cardiovascular, respiratory, cancer, autoimmune, neurodegenerative, and other infectious diseases, as well as for pharmacogenomics. It also engaged in developing and commercializing genomic and protein assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, respiratory virus panel, hemochromatosis, blood infection panel, cardiac troponin I, connective tissue, prostate specific antigen, and biomarker validation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : NSPH
IP Holdings
50-74

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 1 NIH $291,293
Project Title: A Novel Diagnostic Test for Clostridium difficile-Associated Diarrhea (CDAD)
2006 1 Army $100,000
Project Title: Colorimetric Sensors for Chemical and Biological Warfare Agents
2005 2 NIH $849,800
Project Title: Nanoparticle Probe Assay for Biological Threat Agents
2003 2 NIH $867,800
Project Title: Rapid Assay for the I1307k Mutation of the APC Gene
2003 2 NIH $866,198
Project Title: An Assay for Genetic Mutations Causing Hypercoagulation

Key People / Management

  William Moffitt -- President and Chief Executive Officer

  Bill Athenson -- Vice President, Business Development

  William H Cork -- Chief Technology Officer

  Winton G Gibbons -- Senior Vice President of Business Development

  Eva J Gordon

  Michael McGarrity -- Chief Marketing Officer

  Chad A Mirkin -- Former President

  Roger Moody -- Vice President of Finance, Treasurer and Chief Financial Officer

  Tim Patno -- Vice President, Technology

  Greg Shipp -- Vice President, Medical Affairs

  James J Storhoff

  Stephen Wasko -- Chief Financial Officer

Company News

There are no news available.